Annual Net Income
-$80.65 M
-$40.97 M-103.23%
30 June 2024
Summary:
Renovaro Biosciences annual net profit is currently -$80.65 million, with the most recent change of -$40.97 million (-103.23%) on 30 June 2024. During the last 3 years, it has fallen by -$53.93 million (-201.79%). RENB annual net income is now -269633.11% below its all-time high of -$29.90 thousand, reached on 01 March 2012.RENB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$44.21 M
-$28.48 M-181.04%
30 September 2024
Summary:
Renovaro Biosciences quarterly net profit is currently -$44.21 million, with the most recent change of -$28.48 million (-181.04%) on 30 September 2024. Over the past year, it has dropped by -$35.04 million (-381.87%). RENB quarterly net income is now -3876.54% below its all-time high of $1.17 million, reached on 01 June 2019.RENB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$115.69 M
-$35.04 M-43.44%
30 September 2024
Summary:
Renovaro Biosciences TTM net profit is currently -$115.69 million, with the most recent change of -$35.04 million (-43.44%) on 30 September 2024. Over the past year, it has dropped by -$74.53 million (-181.07%).RENB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -103.2% | -381.9% | -181.1% |
| 3 y3 years | -201.8% | -571.6% | -201.4% |
| 5 y5 years | -347.6% | -2469.7% | -1471.2% |
RENB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -201.8% | +28.9% | -921.5% | +51.0% | -201.4% | at low |
| 5 y | 5 years | -606.4% | +28.9% | -2819.3% | +51.0% | -1781.9% | at low |
| alltime | all time | <-9999.0% | +28.9% | -3876.5% | +51.0% | <-9999.0% | at low |
Renovaro Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$44.21 M(+181.0%) | -$115.69 M(+43.4%) |
| June 2024 | -$80.65 M(+103.2%) | -$15.73 M(-69.3%) | -$80.65 M(-8.5%) |
| Mar 2024 | - | -$51.21 M(+1030.8%) | -$88.12 M(+113.7%) |
| Dec 2023 | - | -$4.53 M(-50.6%) | -$41.23 M(+0.2%) |
| Sept 2023 | - | -$9.18 M(-60.4%) | -$41.16 M(+3.7%) |
| June 2023 | -$39.68 M(-65.0%) | - | - |
| June 2023 | - | -$23.20 M(+436.0%) | -$39.68 M(-62.8%) |
| Mar 2023 | - | -$4.33 M(-2.9%) | -$106.72 M(-1.7%) |
| Dec 2022 | - | -$4.46 M(-42.1%) | -$108.60 M(-1.9%) |
| Sept 2022 | - | -$7.70 M(-91.5%) | -$110.72 M(-2.4%) |
| June 2022 | -$113.43 M(+324.5%) | -$90.24 M(+1355.1%) | -$113.43 M(+179.7%) |
| Mar 2022 | - | -$6.20 M(-5.8%) | -$40.56 M(+5.7%) |
| Dec 2021 | - | -$6.58 M(-36.8%) | -$38.39 M(+10.5%) |
| Sept 2021 | - | -$10.41 M(-40.0%) | -$34.74 M(+30.0%) |
| June 2021 | -$26.72 M(+134.1%) | -$17.36 M(+330.8%) | -$26.72 M(+98.6%) |
| Mar 2021 | - | -$4.03 M(+37.4%) | -$13.46 M(+23.0%) |
| Dec 2020 | - | -$2.93 M(+22.4%) | -$10.94 M(+12.5%) |
| Sept 2020 | - | -$2.40 M(-41.5%) | -$9.73 M(-14.8%) |
| June 2020 | -$11.42 M(-36.6%) | -$4.10 M(+170.6%) | -$11.42 M(+85.7%) |
| Mar 2020 | - | -$1.51 M(-12.0%) | -$6.15 M(-16.5%) |
| Dec 2019 | - | -$1.72 M(-57.9%) | -$7.36 M(-66.1%) |
| Sept 2019 | - | -$4.08 M(-448.8%) | -$21.75 M(+20.7%) |
| June 2019 | -$18.02 M(+185.4%) | $1.17 M(-142.9%) | -$18.02 M(-15.2%) |
| Mar 2019 | - | -$2.73 M(-83.1%) | -$21.24 M(-1.1%) |
| Dec 2018 | - | -$16.11 M(+4500.7%) | -$21.47 M(+233.6%) |
| Sept 2018 | - | -$350.10 K(-82.9%) | -$6.44 M(+2.0%) |
| June 2018 | -$6.31 M | -$2.05 M(-30.8%) | -$6.31 M(+41.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$2.96 M(+175.0%) | -$4.45 M(+156.6%) |
| Dec 2017 | - | -$1.08 M(+376.7%) | -$1.73 M(+10.0%) |
| Sept 2017 | - | -$225.80 K(+22.1%) | -$1.58 M(-26.5%) |
| June 2017 | -$2.14 M(+23.5%) | -$184.90 K(-24.9%) | -$2.14 M(-21.0%) |
| Mar 2017 | - | -$246.20 K(-73.2%) | -$2.71 M(+1.4%) |
| Dec 2016 | - | -$918.60 K(+15.8%) | -$2.67 M(+22.8%) |
| Sept 2016 | - | -$793.20 K(+5.0%) | -$2.18 M(+25.5%) |
| June 2016 | -$1.74 M(-35.1%) | -$755.60 K(+264.0%) | -$1.74 M(+77.1%) |
| Mar 2016 | - | -$207.60 K(-50.8%) | -$979.70 K(-51.6%) |
| Dec 2015 | - | -$421.80 K(+20.4%) | -$2.03 M(-20.8%) |
| Sept 2015 | - | -$350.30 K(-72.0%) | -$2.56 M(-20.4%) |
| June 2015 | -$2.67 M(+12.8%) | - | - |
| Mar 2015 | - | -$1.25 M(+31.5%) | -$3.21 M(+34.7%) |
| Dec 2014 | -$2.37 M(+6205.6%) | -$953.10 K(+78.1%) | -$2.38 M(+65.6%) |
| Sept 2014 | - | -$535.20 K(+14.0%) | -$1.44 M(+56.4%) |
| June 2014 | - | -$469.50 K(+10.2%) | -$920.60 K(+102.8%) |
| Mar 2014 | - | -$426.10 K(+4854.7%) | -$454.00 K(+1107.4%) |
| Dec 2013 | - | -$8600.00(-47.6%) | -$37.60 K(-3.1%) |
| Sept 2013 | - | -$16.40 K(+465.5%) | -$38.80 K(+31.5%) |
| June 2013 | - | -$2900.00(-70.1%) | -$29.50 K(-21.5%) |
| Mar 2013 | -$37.60 K(+25.8%) | -$9700.00(-1.0%) | -$37.60 K(+16.4%) |
| Dec 2012 | - | -$9800.00(+38.0%) | -$32.30 K(-4.7%) |
| Sept 2012 | - | -$7100.00(-35.5%) | -$33.90 K(-17.3%) |
| June 2012 | - | -$11.00 K(+150.0%) | -$41.00 K(+36.7%) |
| Mar 2012 | -$29.90 K(-12.8%) | -$4400.00(-61.4%) | -$30.00 K(+17.2%) |
| Dec 2011 | -$34.30 K | -$11.40 K(-19.7%) | -$25.60 K(+80.3%) |
| Sept 2011 | - | -$14.20 K(<-9900.0%) | -$14.20 K(<-9900.0%) |
| June 2011 | - | $0.00 | $0.00 |
FAQ
- What is Renovaro Biosciences annual net profit?
- What is the all time high annual net income for Renovaro Biosciences?
- What is Renovaro Biosciences annual net income year-on-year change?
- What is Renovaro Biosciences quarterly net profit?
- What is the all time high quarterly net income for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly net income year-on-year change?
- What is Renovaro Biosciences TTM net profit?
- What is the all time high TTM net income for Renovaro Biosciences?
- What is Renovaro Biosciences TTM net income year-on-year change?
What is Renovaro Biosciences annual net profit?
The current annual net income of RENB is -$80.65 M
What is the all time high annual net income for Renovaro Biosciences?
Renovaro Biosciences all-time high annual net profit is -$29.90 K
What is Renovaro Biosciences annual net income year-on-year change?
Over the past year, RENB annual net profit has changed by -$40.97 M (-103.23%)
What is Renovaro Biosciences quarterly net profit?
The current quarterly net income of RENB is -$44.21 M
What is the all time high quarterly net income for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly net profit is $1.17 M
What is Renovaro Biosciences quarterly net income year-on-year change?
Over the past year, RENB quarterly net profit has changed by -$35.04 M (-381.87%)
What is Renovaro Biosciences TTM net profit?
The current TTM net income of RENB is -$115.69 M
What is the all time high TTM net income for Renovaro Biosciences?
Renovaro Biosciences all-time high TTM net profit is $0.00
What is Renovaro Biosciences TTM net income year-on-year change?
Over the past year, RENB TTM net profit has changed by -$74.53 M (-181.07%)